| First Author | Tertil M | Year | 2022 |
| Journal | Cell Mol Neurobiol | Volume | 42 |
| Issue | 7 | Pages | 2423-2426 |
| PubMed ID | 33821329 | Mgi Jnum | J:343022 |
| Mgi Id | MGI:7431004 | Doi | 10.1007/s10571-021-01086-3 |
| Citation | Tertil M, et al. (2022) Astroglial Knockout of Glucocorticoid Receptor Attenuates Morphine Withdrawal Symptoms, but Not Antinociception and Tolerance in Mice. Cell Mol Neurobiol 42(7):2423-2426 |
| abstractText | The development of tolerance and drug dependence limit the clinical application of opioids for the treatment of severe pain. Glucocorticoid receptors (GRs) are among molecular substrates involved in these processes. Most studies focus on the role of neuronal GR, while the involvement of GR on glial cells is not fully understood. To address this issue, we used a transgenic model of conditional GR knockout mice, targeted to connexin 30-expressing astrocytes, treated with repeated doses of morphine. We observed no difference between control mice and astrocytic GR knockouts in the development of antinociceptive tolerance. Nevertheless, when animals were subjected to precipitated withdrawal, knockouts presented some attenuated symptoms, including jumping. Taken together, our data suggest that hippocampal and spinal astrocytic GRs appear to be involved in opioid withdrawal, and drugs targeting the GR may relieve some symptoms of morphine withdrawal without influencing its antinociceptive properties. |
